Delivery Order SPE2DR25D3016-SPE2DR26FG2AX
Award Date 12/9/25
Potential Completion Date 12/10/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,613.25 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product used in the treatment of psoriasis, psoriatic arthritis, and ankylosing spondylitis. This competitively awarded, firm fixed-price contract was executed on December 3, 2025, with an ultimate completion date of December 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract...
- The Defense Logistics Agency awarded a $18,220.85 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product used in the treatment of psoriasis and psoriatic arthritis. This firm fixed-price, non-competitive delivery order was executed on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract...
- The Defense Logistics Agency awarded a $10,805.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product commonly used in the treatment of inflammatory conditions. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of July 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $9,760.98 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product used primarily for treating plaque psoriasis and psoriatic arthritis. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $10,948.05 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which...
- The Defense Logistics Agency awarded a delivery order valued at $2,691.01 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product commonly used to treat psoriasis and psoriatic arthritis. This competitively awarded, firm fixed-price delivery order was executed on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $10,496.42. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by October 24, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a $19,860.97 delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on June 26, 2025, with completion expected by June 27, 2025. This firm fixed-price contract represents a non-competitive set-aside and reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs. The order is being performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,710.27 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product commonly used in treating inflammatory conditions. The award was made on November 12, 2025, with an ultimate completion date of November 13, 2025, under a firm fixed price contract type with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,560.10 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product used to treat inflammatory conditions. This non-set-aside, competitively awarded delivery order was executed on November 17, 2025, with an ultimate completion date of November 18, 2025, and operates under firm fixed-price terms. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....